High Prevalence of Celiac Disease in Mexican Mestizo Adults With Type 1 Diabetes Mellitus
| Autor: | José María Remes-Troche, Vicente Andrade-Zarate, María Teresa Ramírez-Iglesias, Fanny Rodriguez-Vallejo, Alberto Rubio-Tapia, Francisco J. López-Maldonado, Francisco Javier Gomez-Perez, Luis Uscanga, Aurelio Ríos-Vaca |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Adult
Male medicine.medical_specialty Biopsy Population Prevalence Gastroenterology Asymptomatic Coeliac disease Diagnosis Differential GTP-Binding Proteins Diabetes mellitus Internal medicine Intestine Small Epidemiology medicine Humans Protein Glutamine gamma Glutamyltransferase 2 Prospective Studies education Mexico Glycated Hemoglobin Type 1 diabetes education.field_of_study Transglutaminases business.industry medicine.disease Antibodies Anti-Idiotypic Immunoglobulin A Surgery Celiac Disease Diabetes Mellitus Type 1 Hemoglobin A Benzamides Female medicine.symptom business Follow-Up Studies |
| Zdroj: | Journal of Clinical Gastroenterology. 42:460-465 |
| ISSN: | 0192-0790 |
| Popis: | Background and Aims: Recent studies have shown that celiac disease (CD) could affect 0.5% to 3% of the general population, including Mexican Mestizos, which represents a complex mixture of genetics, and constitutes the core of Mexican and Latin American populations. However, the association between CD and other conditions, specifically type-1 diabetes mellitus, in this population remains unknown. Thus, our aim was to determine the prevalence of both serologic and biopsy proven CD in Mexican Mestizo adults with type-1 diabetes. Methods: Over a 6-month period, serum samples obtained from consecutive Mexican Mestizo adult patients (age ≥ 18y) with type-1 diabetes were tested with a new generation human recombinant protein based IgA tissue transglutaminase enzyme-linked immunosorbent assay commercial kit. All patients with positive serologic test results underwent upper gastrointestinal endoscopy and small intestinal biopsies to confirm CD. Results: Eighty-four type-1 diabetic patients were included (62 women, mean age 28.9 ± 9y). Overall, 9 patients (9/84) were positive for IgA tissue transglutaminase with a point prevalence of 10.7% (95% CI, 4%-17%). Seven patients agreed to undergo endoscopy. Five subjects had biopsy-proven CD (5.9%, 95% CI, 1.9%-13.3%). One patient had chronic diarrhea and other abdominal bloating; whereas the remaining 3 were asymptomatic. CD associated type-1 diabetic patients tended to have higher hemoglobin A 1c levels (P = 0.07), reflecting poor glycemic control. Conclusions: As in other populations, we demonstrated a high prevalence of biopsy-proven CD (5.9%) among Mexican Mestizo patients with type-1 diabetes. Clinicians should be aware of this common association in this ethnic group. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|